197 related articles for article (PubMed ID: 22378033)
21. Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.
Zhang Y; Wei W; Shilova V; Petrashevskaya NN; Zernetkina VI; Grigorova YN; Marshall CA; Fenner RC; Lehrmann E; Wood WH; Becker KG; Lakatta EG; Bagrov AY; Fedorova OV
J Am Heart Assoc; 2019 Oct; 8(20):e012138. PubMed ID: 31576777
[TBL] [Abstract][Full Text] [Related]
22. The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition.
Fedorova LV; Raju V; El-Okdi N; Shidyak A; Kennedy DJ; Vetteth S; Giovannucci DR; Bagrov AY; Fedorova OV; Shapiro JI; Malhotra D
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F922-34. PubMed ID: 19176701
[TBL] [Abstract][Full Text] [Related]
23. Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.
Averina IV; Tapilskaya NI; Reznik VA; Frolova EV; Fedorova OV; Lakatta EG; Bagrov AY
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):19-23. PubMed ID: 17535731
[TBL] [Abstract][Full Text] [Related]
24. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
[TBL] [Abstract][Full Text] [Related]
25. Involvement of marinobufagenin in a rat model of human preeclampsia.
Vu HV; Ianosi-Irimie MR; Pridjian CA; Whitbred JM; Durst JM; Bagrov AY; Fedorova OV; Pridjian G; Puschett JB
Am J Nephrol; 2005; 25(5):520-8. PubMed ID: 16179779
[TBL] [Abstract][Full Text] [Related]
26. [Preventive effect of trans-resveratrol on hypertension-induced cardiac hypertrophy in partially nephrectomized rats].
Liu ZP; Song Y; Liu ZQ; Zhang XP
Wei Sheng Yan Jiu; 2005 Nov; 34(6):756-8. PubMed ID: 16535856
[TBL] [Abstract][Full Text] [Related]
27. Partial nephrectomy as a model for uremic cardiomyopathy in the mouse.
Kennedy DJ; Elkareh J; Shidyak A; Shapiro AP; Smaili S; Mutgi K; Gupta S; Tian J; Morgan E; Khouri S; Cooper CJ; Periyasamy SM; Xie Z; Malhotra D; Fedorova OV; Bagrov AY; Shapiro JI
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F450-4. PubMed ID: 18032546
[TBL] [Abstract][Full Text] [Related]
28. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7).
Grobe JL; Mecca AP; Lingis M; Shenoy V; Bolton TA; Machado JM; Speth RC; Raizada MK; Katovich MJ
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H736-42. PubMed ID: 17098828
[TBL] [Abstract][Full Text] [Related]
29. Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.
Grigorova YN; Juhasz O; Long JM; Zernetkina VI; Hall ML; Wei W; Morrell CH; Petrashevskaya N; Morrow A; LaNasa KH; Bagrov AY; Rapp PR; Lakatta EG; Fedorova OV
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562955
[TBL] [Abstract][Full Text] [Related]
30. Effects of digoxin-specific antibody Fab fragment (Digibind) on blood pressure and renal water-sodium metabolism in 5/6 reduced renal mass hypertensive rats.
Kaide J; Ura N; Torii T; Nakagawa M; Takada T; Shimamoto K
Am J Hypertens; 1999 Jun; 12(6):611-9. PubMed ID: 10371371
[TBL] [Abstract][Full Text] [Related]
31. Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension.
Jadhav A; Ndisang JF
Exp Biol Med (Maywood); 2009 Jul; 234(7):764-78. PubMed ID: 19429856
[TBL] [Abstract][Full Text] [Related]
32. Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats.
Freundlich M; Li YC; Quiroz Y; Bravo Y; Seeherunvong W; Faul C; Weisinger JR; Rodriguez-Iturbe B
Am J Hypertens; 2014 May; 27(5):720-6. PubMed ID: 24072555
[TBL] [Abstract][Full Text] [Related]
33. N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin.
Liu YH; D'Ambrosio M; Liao TD; Peng H; Rhaleb NE; Sharma U; André S; Gabius HJ; Carretero OA
Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H404-12. PubMed ID: 19098114
[TBL] [Abstract][Full Text] [Related]
34. Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin.
Tian J; Shidyak A; Periyasamy SM; Haller S; Taleb M; El-Okdi N; Elkareh J; Gupta S; Gohara S; Fedorova OV; Cooper CJ; Xie Z; Malhotra D; Bagrov AY; Shapiro JI
Hypertension; 2009 Dec; 54(6):1313-20. PubMed ID: 19884563
[TBL] [Abstract][Full Text] [Related]
35. Effects of intracerebroventricular infusion of Fab fragments of digoxin antibody (Digibind) on development of reduced renal mass-saline hypertension in rats.
Yamada K; Goto A; Hui C; Nagoshi H; Omata M
Hypertens Res; 1995 Jun; 18(2):145-50. PubMed ID: 7584921
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.
Westermann D; Van Linthout S; Dhayat S; Dhayat N; Schmidt A; Noutsias M; Song XY; Spillmann F; Riad A; Schultheiss HP; Tschöpe C
Basic Res Cardiol; 2007 Nov; 102(6):500-7. PubMed ID: 17909696
[TBL] [Abstract][Full Text] [Related]
37. Marinobufagenin, left ventricular geometry and cardiac dysfunction in end-stage kidney disease patients.
Bolignano D; De Rosa S; Greco M; Presta P; Patella G; Crugliano G; Sabatino J; Strangio A; Romano LR; Comi A; Cianfrone P; Andreucci M; Dragone F; Indolfi C; Foti DP; Coppolino G
Int Urol Nephrol; 2022 Oct; 54(10):2581-2589. PubMed ID: 35274285
[TBL] [Abstract][Full Text] [Related]
38. Coordinated shifts in Na/K-ATPase isoforms and their endogenous ligands during cardiac hypertrophy and failure in NaCl-sensitive hypertension.
Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
J Hypertens; 2004 Feb; 22(2):389-97. PubMed ID: 15076199
[TBL] [Abstract][Full Text] [Related]
39. Apocynin Attenuates Cardiac Injury in Type 4 Cardiorenal Syndrome via Suppressing Cardiac Fibroblast Growth Factor-2 With Oxidative Stress Inhibition.
Liu Y; Liu Y; Liu X; Chen J; Zhang K; Huang F; Wang JF; Tang W; Huang H
J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26109504
[TBL] [Abstract][Full Text] [Related]
40. Myocardial PKC beta2 and the sensitivity of Na/K-ATPase to marinobufagenin are reduced by cicletanine in Dahl hypertension.
Fedorova OV; Talan MI; Agalakova NI; Droy-Lefaix MT; Lakatta EG; Bagrov AY
Hypertension; 2003 Mar; 41(3):505-11. PubMed ID: 12623951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
